Is Kyndryl the next MicroStrategy? Why this IBM spinoff is now surging
Is Kyndryl the next MicroStrategy? Why this IBM spinoff is now surging Investing.com
Covered in this story
Analyst targets on IBM
- Morgan Stanley: $234 → $238 by Oct 2027 · Equal-Weight via MarketBeat
- UBS: $231 → $236 by Oct 2027 · Neutral via Investing.com
- Truist Securities: $227 → $240 by Oct 2027 via Pluang
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Dalsna Finance is currently tracking 48 stories mentioning IBM, the earliest published 20 Jul 2026.
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.